GENIBET
GenIbet offers cGMP manufacturing excellence and a comprehensive service that encompasses cell line development, process and analytical development and cGMP production of recombinant proteins, DNA, Viral and Cell products. This, combined with in-house fill and finish capabilities, gives our clients the opportunity to go from bench to clinic in one facility. GenIbet leverages its activities on the extensive expertise in molecular biology, virology, microbial and cell culture of our partner and main shareholder, iBET (Instituto de Biologia Experimental e Tecnológica).
GENIBET
Social Links:
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2006-01-01
Address:
Oeiras, Lisboa, Portugal
Country:
Portugal
Website Url:
http://www.genibet.eu
Total Employee:
11+
Status:
Active
Contact:
351 21 446 9484
Total Funding:
0
Technology used in webpage:
SPF GStatic Google Static Content DoubleClick.Net
Current Employees Featured
Founder
Investors List
Portugal Ventures
Portugal Ventures investment in Seed Round - GenIbet
Official Site Inspections
http://www.genibet.eu
- Host name: 185.53.177.31
- IP address: 185.53.177.31
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "GenIbet"
GenIbet - Crunchbase Company Profile & Funding
Organization. GenIbet . Connect to CRM . Save . Summary. Financials. People. Technology. ... (EU), Europe, Middle East, and Africa (EMEA) Founded Date 2006; ... Phone Number 351 21 446 9484; GenIbet offers cGMP …See details»
Recipharm acquires GenIbet to bolster Biologics offering
GenIbet was founded as a spin-off of Ibet - Instituto de Biologia Experimental e Tecnológica - in 2006 and currently has around 70 employees. Its Portuguese facility is located in Oeiras, just …See details»
GenIbet | Company | ELITE
GenIbet is a biopharmaceutical CMO (Contract Manufacturing Organization) offering highly specialized ELITE Companies and Partners can now access the platform via App ...See details»
Recipharm Acquires Portuguese CDMO, GenIbet, Boosting …
On Feb. 1, 2022, Recipharm announced the acquisition of GenIbet, a Portuguese contract development and manufacturing organization specializing in clinical trial manufacturing and …See details»
Recipharm acquires GenIbet to bolster Biologics offering
Feb 1, 2022 Recipharm AB (publ) Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.comSee details»
Recipharm buys Portuguese CDMO to grow biologics …
Feb 1, 2022 Contract development and manufacturing organization (CDMO), Recipharm, has acquired GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material. Marc Funk, CEO of Stockholm, …See details»
GenIbet - Products, Competitors, Financials, Employees, …
GenIbet is a biopharmaceutical CMO (Contract Manufacturing Organization) that offers specialized microbial, cell culture, and viral propagation process development and cGMP …See details»
GenIbet Biopharmaceuticals (GenIbet) - Cruzivax
Consortium GenIbet Biopharmaceuticals (GenIbet) GenIbet Biopharmaceuticals (GenIbet) is a GMP CDMO offering highly specialized GMP manufacturing and development services to …See details»
GenIBET - Biopharmaceuticals, S.A. - VentureRadar
GenIbet is a cGMP biopharmaceutical CMO (Contract Manufacturing Organization) offering highly specialized microbial, cell culture and viral process development and cGMP manufacturing …See details»
Recipharm Acquires Portuguese CDMO, GenIbet, Boosting
On Feb. 1, 2022, Recipharm announced the acquisition of GenIbet, a Portuguese contract development and manufacturing organization specializing in clinical trial manufacturing and …See details»
Recipharm acquires GenIbet - NLS - Nordic Life Science
Feb 3, 2022 Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The …See details»
RAQUEL FORTUNATO, GENIBET, CEO - Innovations of the World
“GENIBET´S GROWTH HAS BEEN FUELLED BY A COMBINATION OF PEOPLE WITH DIVERSE BACKGROUNDS AND EXPERIENCES”. – RAQUEL FORTUNATO, GENIBET, …See details»
Recipharm will manufacture VOWST on behalf of Seres Therapeutics
May 2, 2023 Recipharm, a global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been …See details»
GenIbet Company Profile - Office Locations, Competitors ... - Craft
GenIbet has 5 employees at their 1 location. See insights on GenIbet including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About Genibet Biopharmaceuticals. - CPHI Online
GenIbet Biopharmaceuticals is a GMP biopharmaceutical CDMO offering highly specialized GMP manufacturing and development services to research groups, Biotech and Pharma companies. …See details»
Genibet | Scientist.com
Genibet.eu: Headquarters: Lisboa, , PT Company Type: Small Business (1-10M TTM Revenue) ... Avenida Da República, Edf. Lisboa, , Portugal: Get started If your organization has a …See details»
GenIbet – COBIOE
Partners & Associates 5 clusters and networks representing European bioproduction ecosystems. Executive Team. Results Check COBIOE progresses and outcomesSee details»
Genibet Company Profile - Office Locations, Competitors ... - Craft
Genibet Summary. Company Summary. Overview. Genibet is a manufacturer of biopharmaceutical products. It offers services such as cGMP manufacturing, process and …See details»
Raquel Fortunato - CEO @ GenIbet - Crunchbase Person Profile
Raquel Fortunato is the CEO of GenIbet. She is a Chemical Engineer with a PhD in Biochemical Engineering and a Post-Graduation in General Management. She has expertise in project …See details»
GenIbet - Contacts, Employees, Board Members, Advisors & Alumni
GenIbet offers cGMP manufacturing excellence and a comprehensive service.See details»